BOOSTRIX 2 UNIT / 0.5 ML
DIPHTHERIA TOXOID : 2 UNIT / 0.5 ML PERTUSSIS TOXOID : 8 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 8 MCG / 0.5 ML TETANUS TOXOID : 20 UNIT / 0.5 ML PERTACTIN : 2.5 MCG / 0.5 ML · DIN 02247600 · GLAXOSMITHKLINE INC
Health Canada status: MARKETED
What is BOOSTRIX?
BOOSTRIX 2 UNIT / 0.5 ML contains DIPHTHERIA TOXOID : 2 UNIT / 0.5 ML PERTUSSIS TOXOID : 8 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 8 MCG / 0.5 ML TETANUS TOXOID : 20 UNIT / 0.5 ML PERTACTIN : 2.5 MCG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02247600, held by GLAXOSMITHKLINE INC, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 29-May-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BOOSTRIX used for?
BOOSTRIX (combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine) is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards, and for passive protection against pertussis in early infancy following maternal immunisation during pregnancy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02247600 |
|---|---|
| Brand name | BOOSTRIX |
| Generic / active ingredient | DIPHTHERIA TOXOID : 2 UNIT / 0.5 ML PERTUSSIS TOXOID : 8 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 8 MCG / 0.5 ML TETANUS TOXOID : 20 UNIT / 0.5 ML PERTACTIN : 2.5 MCG / 0.5 ML |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 2 UNIT / 0.5 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07AX OTHER BACTERIAL VACCINES |
| AHFS class | 80:08.00 ; 80:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-May-2007 |
| Original market date | 2007-05-29 00:00:00 |
How is it administered?
Single 0.5 mL dose by deep intramuscular injection. Not for primary immunization. Booster intervals generally every 10 years. Can be given during third trimester of pregnancy.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
prefilled syringes (type I glass) with a plunger stopper (butyl rubber) and with a rubber tip cap (in packages of 10).
Contraindications
Hypersensitivity to components; encephalopathy within 7 days of previous pertussis vaccine; transient thrombocytopenia or neurological complications after previous diphtheria/tetanus vaccination.
Warnings and precautions
Not for IV use. Postpone in acute severe febrile illness. Potential risk of Guillain-Barré Syndrome or brachial neuritis. Caution in individuals with bleeding disorders/thrombocytopenia.
What can be used instead?
Other Canadian products sharing ATC code J07AX OTHER BACTERIAL VACCINES. 1 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LYMERIX | 30 MCG / 0.5 ML | LIQUID | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02239195 |
| MEGAVAC INJ | 75 M | LIQUID | OMEGA LABORATORIES LIMITED | CANCELLED POST MARKET | DIN 00316393 |
| MRV | 200 M | SUSPENSION | HOLLISTER-STIER LABORATORIES LLC | CANCELLED POST MARKET | DIN 02216981 |
Who else supplies OTHER BACTERIAL VACCINES worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER BACTERIAL VACCINES appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.